AAAAAA
Results:
1-8
|
Results: 8
Authors:
Hryszko, T
Malyszko, J
Malyszko, JS
Brzosko, S
Pawlak, K
Mysliwiec, M
Citation: T. Hryszko et al., A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients, NEPH DIAL T, 16(8), 2001, pp. 1692-1696
Authors:
Borawski, J
Naumnik, B
Pawlak, K
Mysliwiec, M
Citation: J. Borawski et al., Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response, NEPH DIAL T, 16(7), 2001, pp. 1442-1447
Authors:
Borawski, J
Naumnik, B
Pawlak, K
Mysliwiec, M
Citation: J. Borawski et al., Soluble thrombomodulin is associated with viral hepatitis, blood pressure,and medications in haemodialysis patients, NEPH DIAL T, 16(4), 2001, pp. 787-792
Authors:
Brzosko, S
Lebkowska, U
Malyszko, J
Hryszko, T
Pawlak, K
Mysliwiec, M
Citation: S. Brzosko et al., Correlation between carotid intima-media thickness and hematocrit and hemoglobin values in renal transplant recipients, CLIN TRANSP, 15(5), 2001, pp. 349-353
Authors:
Dyszkiewicz, W
Pawlak, K
Gasiorowski, L
Citation: W. Dyszkiewicz et al., Early post-pneumonectomy complications in the elderly, EUR J CAR-T, 17(3), 2000, pp. 246-250
Authors:
Borawski, J
Pawlak, K
Mysliwiec, M
Citation: J. Borawski et al., Comparison of different assays for von Willebrand factor in hemodialysis patients, HAEMOSTASIS, 30(6), 2000, pp. 308-315
Authors:
Malyszko, JS
Malyszko, J
Pawlak, K
Pawlak, D
Buczko, W
Mysliwiec, M
Citation: Js. Malyszko et al., Importance of serotonergic mechanisms in the thrombotic complications in hemodialyzed patients treated with erythropoietin, NEPHRON, 84(4), 2000, pp. 305-311
Authors:
Niedziolka, J
Borzemska, W
Malec, H
Pawlak, K
Citation: J. Niedziolka et al., Effect of artificial electromagnetic fields on chicken embryos and on chicks, ARCH GEFLUG, 62(5), 1998, pp. 234-236
Risultati:
1-8
|